IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,198 | +2220.5% | 114,600 | +1990.1% | 0.05% | +2500.0% |
| Q2 2023 | $224 | -100.0% | 5,483 | -95.5% | 0.00% | -96.0% |
| Q2 2022 | $4,549,000 | +12.3% | 122,897 | +12.4% | 0.05% | +72.4% |
| Q1 2022 | $4,051,000 | -5.7% | 109,376 | -14.6% | 0.03% | +11.5% |
| Q3 2021 | $4,296,000 | +56.9% | 128,087 | +164.5% | 0.03% | -52.7% |
| Q4 2020 | $2,738,000 | +114.9% | 48,427 | +124.0% | 0.06% | +44.7% |
| Q2 2020 | $1,274,000 | -61.2% | 21,624 | -60.5% | 0.04% | -75.5% |
| Q3 2019 | $3,283,000 | – | 54,813 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |